UC - ULCERATIVE COLITIS
Clinical trials for UC - ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new UC - ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for UC - ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ulcerative colitis: experimental drug OD-07656 enters Mid-Stage trial
Disease control Recruiting nowThis study tests a new drug called OD-07656 in people with moderate to severe ulcerative colitis, a chronic bowel disease. The goal is to see if it safely reduces symptoms like bleeding and diarrhea, and if it can make a follow-up treatment (vedolizumab) work better. About 57 adu…
Matched conditions: UC - ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Odyssey Therapeutics • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
Rethinking routine allergy shots: could skipping them improve IBD treatment?
Symptom relief Recruiting nowThis study looks at whether people with moderate-to-severe inflammatory bowel disease (IBD) need to take a steroid (dexamethasone) before each infliximab infusion to prevent allergic reactions. Researchers will compare those who get the routine pre-medication with those who don't…
Matched conditions: UC - ULCERATIVE COLITIS
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC